Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
dociparstat sodium (CX-01)
i
Other names:
CX-01, PGX-100, ODSH, PGX-ODSH-2013-AML-1, PGX 100, DSTAT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Cantex Pharma, Chimerix
Drug class:
CXCL12 inhibitor, CXCR4 antagonist, Cathepsin G inhibitor, HMGB1 inhibitor, Human leukocyte elastase inhibitor, P selectin inhibitor
Related drugs:
‹
tipifarnib (36)
NOX-A12 (3)
GS 6624 (0)
GMI-1359 (4)
mavorixafor (3)
POL 6326 (3)
LY2510924 (1)
BMS-936564 (1)
AT 009 (0)
motixafortide (0)
PTX-9908 (0)
GPC-100 (0)
plerixafor (0)
SBP-101 (0)
crizanlizumab-tmca (0)
tipifarnib (36)
NOX-A12 (3)
GS 6624 (0)
GMI-1359 (4)
mavorixafor (3)
POL 6326 (3)
LY2510924 (1)
BMS-936564 (1)
AT 009 (0)
motixafortide (0)
PTX-9908 (0)
GPC-100 (0)
plerixafor (0)
SBP-101 (0)
crizanlizumab-tmca (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login